Navigation Links
New lung cancer research presented at CHEST 2008
Date:10/27/2008

#7725
YOUNGER PATIENTS WITH LUNG CANCER HAVE BETTER SURVIVAL

(Tuesday, October 28, 1:00 PM EST)

Lung cancer in younger patients may exhibit distinct clinical features than lung cancer in older patients, including better survival rates at each disease stage. Researchers from Stanford Cancer Center in California compared disease characteristics and survival of lung cancer patients aged 15 to 39 years at diagnosis with patients aged ≥40 years at diagnosis. The age-adjusted incidence rate of lung cancer in patients aged 15 to 39 years was 1.2 per 100,000, whereas the rate in patients aged ≥40 years was 141 per 100,000. A higher proportion of younger patients (57 percent) had distant disease at diagnosis compared with older patients (51 percent). Mean 5-year cause-specific survival was 34 percent in the group of patients aged 15 to 39 years and 16 percent in the group aged ≥40 years. In addition, at each disease stage, mean 1- and 5-year cause-specific survival rates were better in the younger group.

#7701
HERBAL REMEDIES MAY HELP PATIENTS WITH ADVANCED LUNG CANCER

(Wednesday, October 29, 1:00 PM EST)

The use of herbal remedies may be an effective supportive therapy to control symptoms and improve quality of life in patients with advanced stage lung cancer. Researchers from Jafary Medical Clinics in West Virginia followed 15 patients with end-stage primary lung cancer who failed to improve with a conventional treatment of chemotherapy and radiation therapy. Patients were treated with American ginseng for fatigue, morphine sulfate for control of severe dyspnea and pain, licorice root powder for control of severe coughing spells, and bilevel pressure ventilation for respiratory depression related to IV morphine. Two patients also were taking oldenlandia, a Chinese herb for lung cancer. Results showed that licorice and ginseng were effective therapies for the majority of patients, and morphine, used as nebulizer in two patients, was effective in the control of marked dyspnea and pain. One patient lived 4 months using the supportive therapy, while the remaining patients lived 6 to 12 weeks.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. Doctors Test Advanced Tool for Treating Prostate Cancer
2. Hooters to Hooters 80 Mile Bicycle Ride Supporting Local American Cancer Society Unit
3. Statins Lower Risk of Clots in Cancer Patients
4. Most Off-Label Cancer Drug Use for Palliative Care
5. Get Screened Video Contest Throws a Spotlight on the Importance of Colorectal-Cancer Screening
6. MicroRNAs make for safer cancer treatments
7. Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan
8. Aflac Cancer Center and Blood Disorders Service Unveils New Carl Edwards Triage Room
9. USC Cancer Center Announces Contribution By Larry and Judy Freeman
10. Study finds that practice makes perfect in lung cancer surgery
11. Researchers Find More Genes Linked to Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, ... its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a ... effective management of complex spine deformity cases, particularly in children. , GSO’s focus ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The California Dental ... in charitable dental services to 1,961 people during the April 22-23 event at the ... charge to Californians who experience barriers to care, CDA Cares educates the public and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
Breaking Medicine Technology: